[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 16, 21 April 2011
Rapid communications Measles resurgence in Belgium from January to mid-April 2011: a preliminary report
M Sabbe <SUP>1</SUP>, D Hue<SUP>1</SUP>, V Hutse<SUP>1</SUP>, P Goubau<SUP>2</SUP><SUP>,3</SUP>
Citation style for this article: Sabbe M, Hue D, Hutse V, Goubau P. Measles resurgence in Belgium from January to mid-April 2011: a preliminary report. Euro Surveill. 2011;16(16):pii=19848. Available online: http://www.eurosurveillance.org/View...rticleId=19848
Date of submission: 15 April 2011 <HR>
From 1 January to 14 April 2011, a total of 155 measles cases were notified in Belgium, whereas throughout 2010, there were only 40. Of the 103 cases with known vaccination status, 87% had not been vaccinated with measles-mumps-rubella vaccine. The resurgence of measles is the consequence of insufficient vaccine coverage in previous years. Efforts to communicate the benefits of measles vaccination to the public and to advise health professionals on control measures and outbreak management are ongoing.
- ------
Eurosurveillance, Volume 16, Issue 16, 21 April 2011
Rapid communications Measles resurgence in Belgium from January to mid-April 2011: a preliminary report
M Sabbe <SUP>1</SUP>, D Hue<SUP>1</SUP>, V Hutse<SUP>1</SUP>, P Goubau<SUP>2</SUP><SUP>,3</SUP>
- Scientific Institute of Public Health, Brussels, Belgium
- Department of Virology, Universit? Catholique de Louvain, Brussels, Belgium
- National committee for the elimination of measles and rubella in Belgium
Citation style for this article: Sabbe M, Hue D, Hutse V, Goubau P. Measles resurgence in Belgium from January to mid-April 2011: a preliminary report. Euro Surveill. 2011;16(16):pii=19848. Available online: http://www.eurosurveillance.org/View...rticleId=19848
Date of submission: 15 April 2011 <HR>
From 1 January to 14 April 2011, a total of 155 measles cases were notified in Belgium, whereas throughout 2010, there were only 40. Of the 103 cases with known vaccination status, 87% had not been vaccinated with measles-mumps-rubella vaccine. The resurgence of measles is the consequence of insufficient vaccine coverage in previous years. Efforts to communicate the benefits of measles vaccination to the public and to advise health professionals on control measures and outbreak management are ongoing.
- ------